Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

50.09 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 182.394171.836178.105180.556145.712140.022135.023120.129123.467120.368120.887112.198101.663103.0295.92183.43185.80684.68883.38380.13779.04779.7989.6975.54371.0458.39360.40257.91665.18756.6763.54364.22368.03359.36676.91263.86853.85356.88655.87759.71149.00345.8754.87659.31862.52452.96352.05
Cost of Revenue 90.34684.54684.53972.15372.97466.18263.85561.61960.11164.54264.65361.01554.28758.07459.08946.92352.62947.86550.00244.88546.6648.88755.00146.28344.88441.33239.82337.27538.4433.84243.58236.61136.31934.46443.74146.2940.53543.60643.91647.9234.00733.36235.24739.03835.03533.40630.28
Gross Profit 92.04887.2993.566108.40372.73873.8471.16858.5163.35655.82656.23451.18347.37644.94636.83236.50833.17736.82333.38135.25232.38730.90334.68929.2626.15617.06120.57920.64126.74722.82819.96127.61231.71424.90233.17117.57813.31813.2811.96111.79114.99612.50819.62920.2827.48919.55721.77
Gross Profit Ratio 0.5050.5080.5250.60.4990.5270.5270.4870.5130.4640.4650.4560.4660.4360.3840.4380.3870.4350.40.440.410.3870.3870.3870.3680.2920.3410.3560.410.4030.3140.430.4660.4190.4310.2750.2470.2330.2140.1970.3060.2730.3580.3420.440.3690.418
Reseach & Development Expenses 14.53414.23317.84816.66416.84319.81517.23618.51422.79816.22317.28610.75918.12214.76518.13317.64416.14915.30319.64418.60615.99614.60716.73411.3415.46814.2611.39310.0410.73211.2512.2779.72310.488.3888.65411.11710.7266.5687.6398.5855.9946.2097.2839.0417.7918.9048.738
General & Administrative Expenses 13.28515.67613.12212.65412.28113.48310.62811.9849.97912.4710.62110.9114.56515.33812.03311.67415.92410.74610.50511.02112.42616.32713.81413.40711.66910.9989.22111.66512.23411.33810.70310.8019.45810.878.7119.03411.30812.4519.779.5568.6386.8458.0069.5456.5136.9076.659
Selling & Marketing Expenses 9.0129.3718.6196.4076.7187.1095.4724.7845.7565.5194.0754.7454.1294.5373.7873.6734.0263.2943.4763.2212.9923.1412.5961.9631.8761.7211.6291.7561.5961.4791.4911.2911.3321.3521.3071.1711.471.5221.4971.4541.3521.2591.291.4621.2031.3941.171
SG&A 22.29725.04721.73819.06118.99920.59216.116.76815.73517.98914.69615.65518.69419.87515.8215.34719.9514.0413.98114.24215.41819.46816.4115.3713.54512.71910.8513.42113.8312.81712.19412.09210.7912.22210.01810.20512.77813.97311.26711.019.998.1049.29611.0077.7168.3017.659
Other Expenses 0.2985.921-5.482-9.041-4.0880.1363.428-0.632-1.6727.5932.9112.8773.601-5.249-9.6213.5751.418-1.6751.43-0.82260.12-0.461-0.9560.043-1.2590.8880.6010.8291.1380.2-0.1130.204-0.3230.051-3.904-0.3790.1761.0641.2070.243-0.26-0.350.0310.2550.1270.0950
Operating Expenses 36.83139.2839.58635.72535.84240.40733.33635.28238.53334.21231.98226.41436.81634.6433.95332.99136.09929.34333.62532.84831.41434.07533.14426.7129.01326.97922.24323.46124.56224.06724.47121.81521.2720.6118.67221.32223.50420.54118.90619.59515.98414.31316.57920.04815.50717.20515.85
Operating Income 55.21748.0153.9872.67836.89626.03737.83215.73724.82329.38824.25224.76910.5610.3062.8793.517-2.9227.48-0.2442.4040.973-3.1721.5452.55-2.857-9.918-1.664-2.822.1851.404-4.515.79710.334.07514.371-3.748-10.26-7.261-7.024-7.817-1.172-1.9692.930.22611.9822.3526.673
Operating Income Ratio 0.3030.2790.3030.4030.2530.1860.280.1310.2010.2440.2010.2210.1040.10.030.042-0.0340.088-0.0030.030.012-0.040.0170.034-0.04-0.17-0.028-0.0490.0340.025-0.0710.090.1520.0690.187-0.059-0.191-0.128-0.126-0.131-0.024-0.0430.0530.0040.1920.0440.128
Total Other Income Expenses Net -4.974-0.134-12.635-9.041-4.0887.5323.4286.859-1.672-0.3552.9112.8773.601-5.249-9.6213.5751.418-1.6751.43-0.82260.12-0.461-0.9560.043-1.2590.8880.6010.8291.1382.843-0.1130.204-0.437-0.166-4.032-0.3830.1021.0641.1280.23-0.444-0.514-0.0890.2490.1270.095-0.999
Income Before Tax 50.24347.87641.34563.63732.80833.56941.2622.59623.15129.03327.16237.64614.2175.114-6.7427.078-1.5045.8051.1861.58261.093-3.6330.5892.574-4.116-9.03-1.063-1.9913.1731.504-4.6236.0019.7523.81610.338-4.276-10.229-6.197-5.817-7.984-1.876-2.4712.7820.33511.9192.1915.674
Income Before Tax Ratio 0.2750.2790.2320.3520.2250.240.3060.1880.1880.2410.2250.3360.140.05-0.070.085-0.0180.0690.0140.020.773-0.0460.0070.034-0.058-0.155-0.018-0.0340.0490.027-0.0730.0930.1430.0640.134-0.067-0.19-0.109-0.104-0.134-0.038-0.0540.0510.0060.1910.0410.109
Income Tax Expense 12.2944.1264.67314.0256.3836.7527.296.5595.5514.0777.1946.6865.5951.155-0.952.285-0.0752.280.4310.59814.173-1.479-1.1290.958-1.326-1.784-2.531-2.1661.2010.611-1.8812.1112.8571.3272.805-1.268-3.582-5.532-3.296-2.605-0.696-0.8520.9530.4944.109-0.1911.312
Net Income 37.94943.17736.16749.22226.12426.03233.91315.87417.34624.25319.7629.5487.7675.041-6.2733.919-0.1923.949-1.0261.3147.7870.8681.8672.389-2.79-7.2461.4680.1751.9720.893-2.7423.896.8952.4897.533-3.008-6.647-0.665-2.521-5.379-1.18-1.6191.829-0.1597.812.3824.362
Net Income Ratio 0.2080.2510.2030.2730.1790.1860.2510.1320.140.2010.1630.2630.0760.049-0.0650.047-0.0020.047-0.0120.0160.6050.0110.0210.032-0.039-0.1240.0240.0030.030.016-0.0430.0610.1010.0420.098-0.047-0.123-0.012-0.045-0.09-0.024-0.0350.033-0.0030.1250.0450.084
EPS 0.780.90.751.010.540.540.70.30.350.470.410.620.160.11-0.130.08-0.0040.09-0.0220.031.010.020.040.05-0.06-0.160.030.0040.040.02-0.060.090.150.060.17-0.066-0.15-0.015-0.057-0.12-0.03-0.0370.23-0.020.980.30.11
EPS Diluted 0.730.810.680.910.490.50.660.30.330.470.390.590.160.1-0.130.08-0.0040.08-0.0220.030.960.020.040.05-0.06-0.160.030.0040.040.02-0.060.080.150.050.17-0.066-0.15-0.015-0.057-0.12-0.03-0.0370.23-0.020.980.30.11
EBITDA 69.36261.97367.76972.67836.89633.43337.83223.22824.82336.18324.25224.76921.16912.0432.87913.923-2.9227.48-0.2442.4040.973-3.1721.5456.813-2.857-9.918-1.664-2.827.252.873-4.515.79713.7887.84513.948-0.677-6.586-7.261-6.866-7.4672.3611.2886.5843.80615.4645.5359.608
EBITDA Ratio 0.380.3610.3810.4030.2530.2390.280.1930.2010.3010.2010.2210.2080.1170.030.167-0.0340.088-0.0030.030.012-0.040.0170.09-0.04-0.17-0.028-0.0490.1110.051-0.0710.090.2030.1320.181-0.011-0.122-0.128-0.123-0.1250.0480.0280.120.0640.2470.1050.185